Eargo, Inc.
EARDelisted Feb 16, 2024- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001719395
Eargo, Inc. was delisted on Feb 16, 2024; its insiders filed their last Form 4 on Feb 20, 2024; 23 institutions reported holding it in 13F filings for Q4 2023, worth $44.2M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Eargo, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
EAR is no longer listed, and 13F filings after Q4 2023 list far fewer holders. See Q4 2023
- Institutional holders
- 0
- −23 vs. Q4 2023
- Shares held
- 0
- −17.1M (−100.0%) vs. Q4 2023
- Total value
- $0
- −$44.2M (−100.0%) vs. Q4 2023
- New holders
- 0
- 0 more added
- Sold out
- 23
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 23 | $44.2M |
| Q3 2023 | 20 | $36.0M |
| Q2 2023 | 19 | $82.4M |
| Q1 2023 | 24 | $78.7M |
| Q4 2022 | 42 | $195.9M |
| Q3 2022 | 48 | $13.0M |
| Q2 2022 | 61 | $11.2M |
| Q1 2022 | 81 | $111.8M |
| Q4 2021 | 87 | $104.6M |
| Q3 2021 | 82 | $144.3M |
| Q2 2021 | 114 | $1.21B |
| Q1 2021 | 80 | $919.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Eargo, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Patient Square Capital LP | 0 | $0 | 0.00% | −15,821,299−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −495,582−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −242,052−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −147,904−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −86,116−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −56,580−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −52,054−100.0% | Sold out |
| Monaco Asset Management SAM | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −47,221−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,984−100.0% | Sold out |
| PenderFund Capital Management Ltd. | 0 | $0 | 0.00% | −12,807−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,376−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −5,041−100.0% | Sold out |
| Byrne Asset Management LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Atlas Capital Advisors LLC | 0 | $0 | 0.00% | −1,223−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,274−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,036−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −710−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −524−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −4−100.0% | Sold out |